Ondine Biomedical (LON:OBI) Trading Down 7.9% – Here’s What Happened

by · The Cerbat Gem

Ondine Biomedical Inc. (LON:OBI – Get Free Report) shares traded down 7.9% during mid-day trading on Wednesday . The stock traded as low as GBX 8 ($0.10) and last traded at GBX 8.29 ($0.11). 121,833 shares were traded during mid-day trading, a decline of 53% from the average session volume of 260,188 shares. The stock had previously closed at GBX 9 ($0.12).

Ondine Biomedical Stock Performance

The company has a market cap of £22.98 million, a PE ratio of -300.00 and a beta of 0.10. The company has a debt-to-equity ratio of 1,847.37, a quick ratio of 8.26 and a current ratio of 0.80. The stock’s 50-day simple moving average is GBX 6.66 and its 200 day simple moving average is GBX 7.19.

About Ondine Biomedical

(Get Free Report)

Ondine Biomedical Inc, a Life sciences company, engages in the research, development, and commercialization of antimicrobial photodisinfection therapies in Canada and internationally. Its product platform is Photodisinfection, a topical light-based antimicrobial technology that eliminates harmful pathogens.

Further Reading